L

Lytix Biopharma AS
OSE:LYTIX

Watchlist Manager
Lytix Biopharma AS
OSE:LYTIX
Watchlist
Price: 6.88 NOK 0.88% Market Closed
Market Cap: 341.3m NOK
Have any thoughts about
Lytix Biopharma AS?
Write Note

Lytix Biopharma AS
Cash from Operating Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Lytix Biopharma AS
Cash from Operating Activities Peer Comparison

Comparables:
HBC
B
BGBIO
AZT
N
NYKD
T
TRMED

Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
L
Lytix Biopharma AS
OSE:LYTIX
Cash from Operating Activities
-kr96m
CAGR 3-Years
-58%
CAGR 5-Years
-6%
CAGR 10-Years
N/A
Hofseth Biocare ASA
OSE:HBC
Cash from Operating Activities
-kr19.2m
CAGR 3-Years
24%
CAGR 5-Years
12%
CAGR 10-Years
15%
B
Bergenbio ASA
OSE:BGBIO
Cash from Operating Activities
-kr175.7m
CAGR 3-Years
14%
CAGR 5-Years
2%
CAGR 10-Years
N/A
Arcticzymes Technologies ASA
OSE:AZT
Cash from Operating Activities
kr20.1m
CAGR 3-Years
-31%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
N
Nykode Therapeutics ASA
OSE:NYKD
Cash from Operating Activities
-$87.4m
CAGR 3-Years
N/A
CAGR 5-Years
-57%
CAGR 10-Years
N/A
T
Thor Medical ASA
OSE:TRMED
Cash from Operating Activities
-kr27.6m
CAGR 3-Years
59%
CAGR 5-Years
40%
CAGR 10-Years
2%

See Also

What is Lytix Biopharma AS's Cash from Operating Activities?
Cash from Operating Activities
-96m NOK

Based on the financial report for Dec 31, 2023, Lytix Biopharma AS's Cash from Operating Activities amounts to -96m NOK.

What is Lytix Biopharma AS's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
-6%

Over the last year, the Cash from Operating Activities growth was -82%. The average annual Cash from Operating Activities growth rates for Lytix Biopharma AS have been -58% over the past three years , -6% over the past five years .

Back to Top